arrow
E

Erica Bonazzina

grande ospedale metropolitano niguarda
H指数:15
被引数:1,213

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial

总新辅助治疗继之以非手术治疗或手术治疗的II~III期直肠癌(NO-CUT):一项多中心、单臂、II期临床试验

2025-11-240
PRE
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies

靶向HER2在转移性结直肠癌中的应用:当前疗法、生物标志物优化及新兴策略

Drugs
IF14.4
2025-11-170
OAAI
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset

pT4N0结肠癌的预后影响与临床管理:来自大型、多中心、国际、真实世界数据集的数据

2025-07-150
OAAI
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

甲基BEAMing和液滴数字PCR检测MGMT基因启动子甲基化的比较研究

2024-11-050
OA
Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial

完全新辅助治疗(TNT)联合非手术治疗(NOM)用于 proficient 错配修复的局部晚期直肠癌(pMMR LARC):NO-CUT 试验的初步结果

2024-09-013
PRE
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer

循环肿瘤DNA驱动转移性结直肠癌的治疗

2023-07-128
OAAI
Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer ( vol 12, 1030232, 2022)

病例报告: MAP2K1 K57N突变与转移性结直肠癌抗EGFR单克隆抗体原发性耐药相关 (第12卷,1030232,2022)

2023-03-282
OAAI
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

病例报告: MAP2K1 K57N突变与转移性结直肠癌抗EGFR单克隆抗体原发性耐药相关

2022-11-074
OAAI
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer
2020-12-0173
OAAI
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib

高循环甲基化DNA是接受Regorafenib治疗的转移性结直肠癌患者的阴性预测和预后标志物

2019-07-1226
OAAI
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies

抗EGFR单克隆抗体在转移性结直肠癌中的再治疗: 不同策略的系统评价

2019-02-0179
PREAI
Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer
2018-07-010
PRE